儿童TRPM1相关先天性静止性夜盲的表现
该回顾性纵向病例系列描述了7例经分子确诊的TRPM1相关完全型先天性静止性夜盲(cCSNB)患儿,平均随访11.1年。患儿多在学龄前因进行性近视、斜视和/或眼球震颤就诊,而非夜盲主诉;全视野视网膜电图呈负波型且振幅稳定,全视野刺激阈值中度异常,视野I2e等视线收缩。作者认为对早发性近视(尤其伴斜视和/或眼球震颤)儿童应考虑ffERG和cCSNB基因检测。
要点
- TRPM1相关cCSNB患儿多在学龄前因进行性近视、斜视和/或眼球震颤就诊,而非夜盲主诉。
- 全视野视网膜电图呈负波型且随访中振幅稳定,全视野刺激阈值中度异常,视野I2e等视线收缩。
- 作者认为对早发性近视(尤其伴斜视和/或眼球震颤)儿童应考虑ffERG和cCSNB基因检测。
核心结论
- TRPM1相关cCSNB患儿在学龄前表现为进行性近视以及斜视和眼球震颤(而非夜盲),全视野视网膜电图呈稳定的负波型,全视野刺激阈值轻度异常,视野I2e等视线收缩。
- 这些发现提示对早发性近视(尤其伴斜视和/或眼球震颤)儿童应考虑ffERG和cCSNB基因检测,且TRPM1相关cCSNB是一种可能在儿童期无夜盲主诉的离子通道病。
研究设计与样本
- 该研究为爱荷华大学1990年1月1日至2015年7月1日开展的回顾性纵向病例系列,纳入7例经分子确诊的TRPM1相关cCSNB儿童(5例[71.4%]女性),平均(标准差)随访11.1(2.8)年。
主要发现
- 7例患儿中,斜视6例(86%)、近视5例(71%)、眼球震颤3例(43%);平均(标准差)就诊年龄8(4)个月,ffERG诊断年龄7.3岁,分子诊断年龄9.7岁。
- 末次随访时较好眼最佳矫正视力平均20/30(范围20/20-20/60);初始屈光度平均(标准差)-2.80(4.42)D,末次随访平均-8.75(3.53)D(范围-4.00至-13.75 D),近视漂移在5岁前最快。
- 全视野视网膜电图呈负波型,符合cCSNB,随访中振幅无显著变化;就诊时无患儿或家长注意到夜盲,但最终有5/7例(71%)报告主观夜盲。
- 全视野刺激阈值中度低于正常(-29.7[3.8] dB;正常-59.8[4.0] dB);Goldmann视野I-4e等视线完整,但I-2e等视线收缩。
- 检测到8种预测致病的TRPM1不同突变或罕见变异,其中3种为新变异。
临床怎么用
- 作者认为,对表现为早发性近视的儿童,尤其伴有斜视和/或眼球震颤时,应考虑ffERG和cCSNB基因检测。
- 作者指出,TRPM1相关cCSNB是一种可能在儿童期无夜盲主诉的离子通道病。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Congenital stationary night blindness (CSNB) implies a stable condition, with the major symptom being nyctalopia present at birth. Pediatric clinical presentation and the course of different genetic subtypes of CSNB have not, to our knowledge, been well described in the era of molecular genetic diagnosis. OBJECTIVE: To describe the presentation and longitudinal clinical characteristics of pediatric patients with molecularly confirmed TRPM1-associated complete CSNB (cCSNB). DESIGN, SETTING, PARTICIPANTS: This study was conducted at the University of Iowa from January 1, 1990, to July 1, 2015, and was a retrospective, longitudinal case series of 7 children (5 [71.4%] female) with TRPM1-associated cCSNB followed up for a mean (SD) of 11.1 (2.8) years. MAIN OUTCOMES AND MEASURES: History, ophthalmologic examination findings, full-field electroretinogram (ffERG) results, full-field stimulus threshold testing results, Goldmann visual field results, optical coherence tomography results, and molecular genetic results were evaluated. Presenting symptoms and signs, the correlation of refractive error with electroretinography, and clinical evolution were analyzed. RESULTS: Seven patients (5 [71.4%] female) presented early in childhood with strabismus (n = 6 [86%]), myopia (n = 5 [71%]), and/or nystagmus (n = 3 [43%]). The mean (SD) age at presentation was 8 (4) months and for receiving a diagnosis by ffERG was 7.3 years, with molecular diagnosis at 9.7 years. The mean (SD) length of follow-up was 11 (2.8) years. The best-corrected visual acuity at the most recent visit averaged 20/30 in the better-seeing eye (range, 20/20-20/60). The mean (SD) initial refraction was -2.80 (4.42) diopters (D) and the mean refraction at the most recent visit was -8.75 (3.53) D (range, -4.00 to -13.75 D), with the greatest rate of myopic shift before age 5 years. Full-field electroretinogram results were electronegative, consistent with cCSNB, without a significant change in amplitude over time. No patient or parent noted night blindness at presentation; however, subjective nyctalopia was eventually reported in 5 of 7 patients (71%). The full-field stimulus threshold testing results were moderately subnormal (-29.7 [3.8] dB; normal -59.8 [4.0] dB). Goldmann visual field results were significant for full I-4e, but constricted I-2e isopter. Eight different mutations or rare variants in TRPM1 predicted to be pathogenic were detected, with 3 novel variants. CONCLUSIONS AND RELEVANCE: Children with TRPM1-associated cCSNB presented before school age with progressive myopia as well as strabismus and nystagmus (but not nyctalopia), with stable, electronegative ffERG results, mildly subnormal full-field stimulus threshold testing results, and a constricted I2e isopter on perimetry. These findings suggest that ffERG and cCSNB genetic testing should be considered for children who present with early-onset myopia, especially in the presence of strabismus and/or nystagmus, and that TRPM1-associated cCSNB is a channelopathy that may present without complaints of night blindness in childhood.
引用
- Miraldi Utz V, Pfeifer W, Longmuir SQ, et al. Presentation of TRPM1-Associated Congenital Stationary Night Blindness in Children. JAMA Ophthalmol. 2018. PMID: 29522070. doi:10.1001/jamaophthalmol.2018.0185
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。